Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Revenue (2017 - 2025)

Historic Revenue for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $54.5 million.

  • Puma Biotechnology's Revenue fell 3236.45% to $54.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $212.0 million, marking a year-over-year decrease of 1296.31%. This contributed to the annual value of $230.5 million for FY2024, which is 219.36% down from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Revenue is $54.5 million, which was down 3236.45% from $52.4 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Revenue registered a high of $98.2 million during Q1 2021, and its lowest value of $43.8 million during Q1 2024.
  • Its 5-year average for Revenue is $59.1 million, with a median of $54.6 million in 2023.
  • In the last 5 years, Puma Biotechnology's Revenue surged by 9167.27% in 2021 and then plummeted by 5341.1% in 2022.
  • Quarter analysis of 5 years shows Puma Biotechnology's Revenue stood at $55.4 million in 2021, then surged by 58.33% to $87.6 million in 2022, then fell by 17.65% to $72.2 million in 2023, then dropped by 18.15% to $59.1 million in 2024, then decreased by 7.79% to $54.5 million in 2025.
  • Its last three reported values are $54.5 million in Q3 2025, $52.4 million for Q2 2025, and $46.0 million during Q1 2025.